1. United States
2. Wisc.
3. Letter

**Oppose Harmful Drug Tariffs That Will Hurt Vulnerable Patients** I am writing to express my deep concern about President Trump's recently announced tariffs on imported brand name drugs, set to begin in October 2025. This policy, while ostensibly aimed at boosting domestic pharmaceutical manufacturing, poses a significant threat to our most vulnerable citizens – the elderly and chronically ill patients who rely on these medications. The proposed 100% duty on branded or patented pharmaceutical products imported to the United States is alarming. While generic drugs, which account for about 90% of prescriptions filled in the US, are expected to be exempt, many of our sickest patients depend on specific brand name medications that have no generic alternatives. The complexity of drug pricing means we cannot predict with certainty how these tariffs will affect consumer costs. However, industry experts warn that such steep tariffs could lead to higher prices and potential shortages. For elderly patients on fixed incomes and those managing chronic conditions, any increase in drug prices could be catastrophic, forcing impossible choices between vital medications and other necessities. Furthermore, this policy may have unintended consequences for the US pharmaceutical industry. The tariffs could disrupt carefully laid plans for drug manufacturing and investments, potentially slowing innovation and drug development at a time when we need medical advancements more than ever. I urge you to oppose these tariffs and instead advocate for policies that protect patient access to affordable medications while encouraging domestic pharmaceutical production through more targeted incentives. Our approach to healthcare and drug pricing should prioritize the well-being of our most vulnerable citizens, not risk their health with punitive trade measures. Please consider the human cost of this policy. Act now to prevent these tariffs from taking effect and work towards solutions that ensure all Americans can access the medications they need without financial hardship.